We further validated that knockdown of MAT2A through overexpression of circARHGAP10 and restriction of methionine up-take was sufficient to overcome cisplatin resistance in vivo in immuno-deficiency model but not in immuno- competent model. This evidence concerns the gene MAT2A and immunodeficiency disease.